Results 201 to 210 of about 16,685 (240)
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1974 openaire +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Lancet, 2023
Polymyalgia rheumatica is an inflammatory disease producing pain and stiffness, mainly in the shoulders and pelvic girdle, in people older than 50 years. Elevation of acute phase reactants is common due to the inflammatory nature of the disease. Since there are no specific diagnostic tests, diagnosis requires the exclusion of other diseases with ...
Espigol-Frigole G. +5 more
openaire +4 more sources
Polymyalgia rheumatica is an inflammatory disease producing pain and stiffness, mainly in the shoulders and pelvic girdle, in people older than 50 years. Elevation of acute phase reactants is common due to the inflammatory nature of the disease. Since there are no specific diagnostic tests, diagnosis requires the exclusion of other diseases with ...
Espigol-Frigole G. +5 more
openaire +4 more sources
BMJ, 2013
Polymyalgia rheumatica is a chronic, inflammatory disorder of unknown cause that affects people over age 50 years. Classic symptoms include pain and long-term morning stiffness of the neck, shoulders, hips, upper arms, and thighs. Although markers of inflammation are often raised, no specific laboratory test exists for the disorder and the diagnosis is
Sarah L, Mackie, Christian D, Mallen
+8 more sources
Polymyalgia rheumatica is a chronic, inflammatory disorder of unknown cause that affects people over age 50 years. Classic symptoms include pain and long-term morning stiffness of the neck, shoulders, hips, upper arms, and thighs. Although markers of inflammation are often raised, no specific laboratory test exists for the disorder and the diagnosis is
Sarah L, Mackie, Christian D, Mallen
+8 more sources
Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper.
New England Journal of Medicine, 2023BACKGROUND More than half of patients with polymyalgia rheumatica have a relapse during tapering of glucocorticoid therapy. Previous studies have suggested that interleukin-6 blockade may be clinically useful in the treatment of polymyalgia rheumatica ...
R. Spiera +16 more
semanticscholar +1 more source
Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica
Annals of the Rheumatic Diseases, 2023Objective The aim of the present study was to determine the clinical significance of subclinical giant cell arteritis (GCA) in polymyalgia rheumatica (PMR) and ascertain its optimal treatment approach.
E. de Miguel +14 more
semanticscholar +1 more source
Annals of the Rheumatic Diseases, 2022
Background Polymyalgia rheumatica is the second most common inflammatory rheumatic disease of people >50 years. Glucocorticoid therapy is highly effective, but many patients require treatment for several years. Effective glucocorticoid sparing agents are
M. Bonelli +10 more
semanticscholar +1 more source
Background Polymyalgia rheumatica is the second most common inflammatory rheumatic disease of people >50 years. Glucocorticoid therapy is highly effective, but many patients require treatment for several years. Effective glucocorticoid sparing agents are
M. Bonelli +10 more
semanticscholar +1 more source
Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica.
Rheumatology, 2023OBJECTIVE The main objective of this study was to analyse the prevalence and characteristics of subclinical GCA in patients with PMR. METHODS This was a cross-sectional multicentre international study of consecutive patients with newly diagnosed PMR ...
E. de Miguel +12 more
semanticscholar +1 more source
Arthritis care & research, 2023
This study describes the demographics, comorbidities, and treatment patterns in a national cohort of patients with polymyalgia rheumatica (PMR) who received care from rheumatology providers.
S. Sattui +5 more
semanticscholar +1 more source
This study describes the demographics, comorbidities, and treatment patterns in a national cohort of patients with polymyalgia rheumatica (PMR) who received care from rheumatology providers.
S. Sattui +5 more
semanticscholar +1 more source
Journal of Internal Medicine, 2022
Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are systemic inflammatory diseases that primarily affect elderly women.
D. Michailidou +3 more
semanticscholar +1 more source
Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are systemic inflammatory diseases that primarily affect elderly women.
D. Michailidou +3 more
semanticscholar +1 more source